Study S000202

Effects of Exenatide on Motor Function and the Brain

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03456687
Study type: INTERVENTIONAL
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 5
Start: 2018-06-05
Primary completion: 2020-10-16
Lead sponsor: University of Florida
Conditions: Parkinson's Disease
Interventions: DRUG:Exenatide
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: NIH:R01NS052318; OTHER:OCR17539

Registered primary outcomes

Change in free-water accumulation in the substantia nigra [Baseline and one-year]
Change in blood oxygen level-dependent(BOLD) signal in the posterior putamen. [Baseline and one-year]
Change in blood oxygen level-dependent(BOLD) signal in M1. [Baseline and one-year]
Change in blood oxygen level-dependent(BOLD) signal in the supplementary motor area(SMA). [Baseline and one-year]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.